Actual Medicinal Product (AMP) AlfaD 0.25microgram capsules (Theramex HQ UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Medicines suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
- Notes
-
No special precautions for storage.
- Provenance
-
This compatibility recommendation is derived from One-Alpha 250nanogram capsules (Neon Healthcare Ltd) and Alfacalcidol 250nanogram capsules (Strides Pharma UK Ltd).
- Generic
- Alfacalcidol
- Formulation
- Alfacalcidol 250nanogram capsules
-
Alfacalcidol
-
Alfacalcidol 250nanogram capsules
-
AlfaD 0.25microgram capsules (Theramex HQ UK Ltd)
-
-